Literature DB >> 15750673

[Topical treatment of subacute-cutaneous lupus erythematosus with tacrolimus].

S Meller1, D Bruch-Gerharz, T Ruzicka, B Homey.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15750673     DOI： 10.1007/s00105-005-0921-x

Source DB:  PubMed          Journal:  Hautarzt        ISSN： 0017-8470            Impact factor:   0.751


× No keyword cloud information.
  10 in total

1.  Topical tacrolimus as a therapeutic adjunct in patients with cutaneous lupus erythematosus. A report of three cases.

Authors:  Markus Böhm; Markus Gaubitz; Thomas A Luger; Dieter Metze; Gisela Bonsmann
Journal:  Dermatology       Date:  2003       Impact factor: 5.366

2.  0.1% Tacrolimus ointment in a patient with subacute cutaneous lupus erythematosus.

Authors:  A Drüke; T Gambichler; P Altmeyer; M Freitag; A Kreuter
Journal:  J Dermatolog Treat       Date:  2004-01       Impact factor: 3.359

3.  Treatment of chronic discoid lupus erythematosus with topical tacrolimus.

Authors:  Daniel de la Rosa Carrillo; Ole B Christensen
Journal:  Acta Derm Venereol       Date:  2004       Impact factor: 4.437

4.  Topical FK506 (tacrolimus) therapy for facial erythematous lesions of cutaneous lupus erythematosus and dermatomyositis.

Authors:  Takashi Yoshimasu; Toshio Ohtani; Taiko Sakamoto; Akihiro Oshima; Fukumi Furukawa
Journal:  Eur J Dermatol       Date:  2002 Jan-Feb       Impact factor: 3.328

Review 5.  Subacute cutaneous lupus erythematosus: a decade's perspective.

Authors:  R D Sontheimer
Journal:  Med Clin North Am       Date:  1989-09       Impact factor: 5.456

6.  Efficacy of topical tacrolimus for treating the malar rash of systemic lupus erythematosus.

Authors:  T Kanekura; N Yoshii; K Terasaki; H Miyoshi; T Kanzaki
Journal:  Br J Dermatol       Date:  2003-02       Impact factor: 9.302

7.  Successful treatment of subacute cutaneous lupus erythematosus with mycophenolate mofetil.

Authors:  S Schanz; A Ulmer; G Rassner; G Fierlbeck
Journal:  Br J Dermatol       Date:  2002-07       Impact factor: 9.302

8.  Topical tacrolimus therapy of resistant cutaneous lesions in lupus erythematosus: a possible alternative.

Authors:  C E Lampropoulos; S Sangle; P Harrison; G R V Hughes; D P D'Cruz
Journal:  Rheumatology (Oxford)       Date:  2004-07-20       Impact factor: 7.580

Review 9.  Potential future dermatological indications for tacrolimus ointment.

Authors:  Thomas Ruzicka; Till Assmann; Mark Lebwohl
Journal:  Eur J Dermatol       Date:  2003 Jul-Aug       Impact factor: 3.328

Review 10.  Subacute cutaneous lupus erythematosus.

Authors:  K M David-Bajar
Journal:  J Invest Dermatol       Date:  1993-01       Impact factor: 8.551
  10 in total
  2 in total

1.  Topical calcineurin inhibitors in systemic lupus erythematosus.

Authors:  Christos E Lampropoulos; David P D'Cruz
Journal:  Ther Clin Risk Manag       Date:  2010-04-15       Impact factor: 2.423

2.  Update on the use of topical calcineurin inhibitors in cutaneous lupus erythematosus.

Authors:  Michael Sticherling
Journal:  Biologics       Date:  2011-02-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.